Hiv-1
📧 Sign up to get email alerts when something new happens for Hiv-1.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: HIV-1, Insufficient Sleep and Vascular Endothelial Dysfunction [NA]
A completed clinical trial assessing the relationship between HIV-1 infection, insufficient sleep, and vascular endothelial dysfunction, wit…
-
CLINICAL_TRIALS trial_result · 2022-12-07Clinical Trial Update: Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention [Phase 3]
A Phase 3 trial assessing a responsive intervention to prevent mother-to-child transmission of HIV-1 has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEV [Phase 2]
Phase 2 trial update on a rescue intervention to prevent childhood HIV infection.
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants [Phase 3]
Clinical trial update indicating continued access to etravirine (ETR) for treatment-experienced HIV-1 infected participants in Phase 3; stud…
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care [Phase 3]
Phase 3 study evaluating the efficacy and safety of the once-daily fixed-dose combination doravirine/lamivudine/emtricitabine/tenofovir alaf…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-03Clinical Trial Update: A Study of Islatravir (MK-8591) in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003) [Phase 1]
Phase 1 trial of islatravir (MK-8591) in ART-naive HIV-1 infected participants has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients [Phase 4]
This Phase 4 trial compares metabolic effects of boosted protease inhibitor regimens—atazanavir/ritonavir versus darunavir/ritonavir—each wi…
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: PEPI-TiDP23-C103: First-in-Human Study to Examine the Safety, Tolerability, and Plasma Pharmacokinetics of Increasing Single and Repeated Oral Doses of TMC558445 and of a Combined Single Day Dosing of Oral TMC558445 and Oral TMC310911 and Also Oral Darunavir [Phase 1]
A first-in-human Phase 1 study evaluated safety, tolerability, and plasma pharmacokinetics of escalating single and repeated oral doses of T…